Integrated Analysis of LncRNA-mRNA Co-Expression Profiles in Patients with Moyamoya Disease

Overexpression of the long noncoding RNA TUG1 protects against cold-induced injury of mouse livers by inhibiting apoptosis and inflammation

(2016) Song Su et al.   FEBS Journal

Cepharanthine inhibits in vitro VSMC proliferation and migration and vascular inflammatory responses mediated by RAW264.7

(2016) Keshav Raj Paudel et al.   TOXICOLOGY IN VITRO

Tumor-suppressive function of long noncoding RNA MALAT1 in glioma cells by downregulation of MMP2 and inactivation of ERK/MAPK signaling

(2016) Y Han et al.   Cell Death & Disease

Differentially expressed lncRNAs and mRNAs identified by microarray analysis in GBS patients vs healthy controls

(2016) Jing Xu et al.   Scientific Reports

Long Noncoding RNAs and Their Regulatory Network: Potential Therapeutic Targets for Adult Moyamoya Disease

(2016) Faliang Gao et al.   World Neurosurgery

Long Intergenic Noncoding RNAs Mediate the Human Chondrocyte Inflammatory Response and Are Differentially Expressed in Osteoarthritis Cartilage

(2016) Mark J. Pearson et al.   Arthritis & Rheumatology

The Pathophysiology of Moyamoya Disease: An Update

(2016) Oh Young Bang et al.   Journal of Stroke

Moyamoya Disease: Epidemiology, Clinical Features, and Diagnosis

(2016) Jong S. Kim   Journal of Stroke

Roles, Functions, and Mechanisms of Long Non-coding RNAs in Cancer

(2016) Yiwen Fang et al.   GENOMICS PROTEOMICS & BIOINFORMATICS

Volatile anaesthetics reduce neutrophil inflammatory response by interfering with CXC receptor-2 signalling

(2015) B. Müller-Edenborn et al.   BRITISH JOURNAL OF ANAESTHESIA

The lncRNA MALAT1 protects the endothelium against ox-LDL-induced dysfunction via upregulating the expression of the miR-22-3p target genes CXCR2 and AKT

(2015) Yong Tang et al.   FEBS LETTERS

Icariin Attenuates High-cholesterol Diet Induced Atherosclerosis in Rats by Inhibition of Inflammatory Response and p38 MAPK Signaling Pathway

(2015) Yanwu Hu et al.   INFLAMMATION

Aberrant expression of long noncoding RNAs in cumulus cells isolated from PCOS patients

(2015) Xin Huang et al.   JOURNAL OF ASSISTED REPRODUCTION AND GENETICS

Long non-coding RNA ANRIL regulates inflammatory responses as a novel component of NF-κB pathway

(2015) Xiao Zhou et al.   RNA Biology

Long noncoding RNA HOTAIR, a hypoxia-inducible factor-1α activated driver of malignancy, enhances hypoxic cancer cell proliferation, migration, and invasion in non-small cell lung cancer

(2015) Chunxia Zhou et al.   TUMOR BIOLOGY

Moyamoya disease susceptibility gene RNF213 links inflammatory and angiogenic signals in endothelial cells

(2015) Kazuhiro Ohkubo et al.   Scientific Reports

Platelet-derived growth factor-BB induces matrix metalloproteinase-2 expression and rat vascular smooth muscle cell migration via ROCK and ERK/p38 MAPK pathways

(2014) Ying Cui et al.   MOLECULAR AND CELLULAR BIOCHEMISTRY

Serum miRNA Signature in Moyamoya Disease

(2014) Dongwei Dai et al.   PLoS One

Long non-coding RNAs in the regulation of the immune response

(2014) James A. Heward et al.   TRENDS IN IMMUNOLOGY

Genetics and Biomarkers of Moyamoya Disease: Significance ofRNF213as a Susceptibility Gene

(2014) Miki Fujimura et al.   Journal of Stroke

Transforming Growth Factor β Inhibits Platelet Derived Growth Factor-Induced Vascular Smooth Muscle Cell Proliferation via Akt-Independent, Smad-Mediated Cyclin D1 Downregulation

(2013) Abel Martin-Garrido et al.   PLoS One

The long noncoding RNA THRIL regulates TNF  expression through its interaction with hnRNPL

(2013) Z. Li et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Long Noncoding RNA Related to Cartilage Injury Promotes Chondrocyte Extracellular Matrix Degradation in Osteoarthritis

(2013) Qiang Liu et al.   Arthritis & Rheumatology

Analysis of TGFB1 in European and Japanese Moyamoya disease patients

(2012) Chao Liu et al.   European Journal of Medical Genetics

Transforming growth factor-β increases vascular smooth muscle cell proliferation through the Smad3 and extracellular signal-regulated kinase mitogen-activated protein kinases pathways

(2012) Pasithorn A. Suwanabol et al.   JOURNAL OF VASCULAR SURGERY

RNA discrimination

(2012) Monika S. Kowalczyk et al.   NATURE

A ceRNA Hypothesis: The Rosetta Stone of a Hidden RNA Language?

(2011) Leonardo Salmena et al.   CELL

Age-specific eNOS polymorphisms in moyamoya disease

(2011) Young Seok Park et al.   CHILDS NERVOUS SYSTEM

Moyamoya disease: a review of histopathology, biochemistry, and genetics

(2011) David G. Weinberg et al.   Neurosurgical Focus

Moyamoya Disease in China

(2011) Lian Duan et al.   STROKE

Polymorphisms in TGFB1 and PDGFRB are associated with Moyamoya disease in European patients

(2010) Constantin Roder et al.   ACTA NEUROCHIRURGICA

Association of a Functional Polymorphism in the MMP-3 Gene with Moyamoya Disease in the Chinese Han Population

(2010) Hao Li et al.   CEREBROVASCULAR DISEASES

A genome-wide association study identifies RNF213 as the first Moyamoya disease gene

(2010) Fumiaki Kamada et al.   JOURNAL OF HUMAN GENETICS

Epidemiological and clinical features of Moyamoya disease in Nanjing, China

(2009) Wei Miao et al.   CLINICAL NEUROLOGY AND NEUROSURGERY

Long non-coding RNAs: insights into functions

(2009) Tim R. Mercer et al.   NATURE REVIEWS GENETICS

A rare Asian founder polymorphism of Raptor may explain the high prevalence of Moyamoya disease among East Asians and its low prevalence among Caucasians

(2009) Wanyang Liu et al.   Environmental Health and Preventive Medicine

Efficacy of the revascularization surgery for adult-onset moyamoya disease with the progression of cerebrovascular lesions

(2008) Ayumi Narisawa et al.   CLINICAL NEUROLOGY AND NEUROSURGERY

Moyamoya disease: current concepts and future perspectives

(2008) Satoshi Kuroda et al.   LANCET NEUROLOGY

Prevalence and Clinicoepidemiological Features of Moyamoya Disease in Japan

(2007) Shinichi Kuriyama et al.   STROKE